Trials / Conditions / Diffuse Systemic Sclerosis
Diffuse Systemic Sclerosis
6 registered clinical trials studyying Diffuse Systemic Sclerosis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases NCT07439029 | Children's Hospital of Fudan University | Phase 1 |
| Terminated | A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients NCT04837131 | Michael M. Pham | Phase 2 |
| Recruiting | Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults NCT07000916 | Université Catholique de Louvain | — |
| Completed | IL1-TRAP, Rilonacept, in Systemic Sclerosis NCT01538719 | Boston University | Phase 1 / Phase 2 |
| Completed | Fresolimumab In Systemic Sclerosis NCT01284322 | Boston University | Phase 1 |
| Unknown | Serial Night Time Position Splint on Systemic Sclerosis NCT01586663 | Federal University of São Paulo | Phase 3 |